Evaluation of mupirocin ointment in control of central venous catheter related infections: A randomized clinical trial

Tehran University Medical Journal

Volumn 67, Issue 6, 2009, Pages 428-434

  Rezaei, J ^a   Esfandiari, Kh ^a   Tavakoli, H ^a   Sadooghi, M ^a   Hasibi, M ^a   Behzadi, M ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Central venous catheter; Mupirocin; Nosocomial infection

Indexed keywords

CHLORHEXIDINE; ENOXAPARIN; PSEUDOMONIC ACID;

ARTICLE; BACTERIAL COLONIZATION; BLOODSTREAM INFECTION; CATHETER; CENTRAL VENOUS CATHETER; CLINICAL TRIAL; CONTROL GROUP; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE INFECTION; DRUG EFFICACY; HUMAN; INFECTION CONTROL; JUGULAR VEIN; MAJOR CLINICAL STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEX;

EID: 77953427352     PISSN: 16831764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Ann Intern Med 1997; 127(4): 257-66.
2. McGee DC, Gould MK. Preventing complications of central venous catheterization. N Engl J Med 2003; 348(12): 1123-33.
3. Miller DL, O'Grady NP. Guidelines for the prevention of intravascular catheter-related infections: recommendations relevant to interventional radiology. J Vasc Interv Radiol 2003; 14(9 Pt 2): S355-8.
4. Mermel LA. Prevention of intravascular catheter-related infections. Ann Intern Med 2000; 132(5): 391-402.
5. Raad I. Intravascular-catheter-related infections. Lancet 1998; 351(9106): 893-8.
6. Moretti EW, Ofstead CL, Kristy RM, Wetzler HP. Impact of central venous catheter type and methods on catheter-related colonization and bacteraemia. J Hosp Infect 2005; 61(2): 139-45.
7. Safdar N, Kluger DM, Maki DG. A review of risk factors for catheter-related bloodstream infection caused by percutaneously inserted, noncuffed central venous catheters: implications for preventive strategies. Medicine (Baltimore) 2002; 81(6): 466-79.
8. Abdelkefi A, Torjman L, Ladeb S, Othman TB, Achour W, Lakhal A, et al. Randomized trial of prevention of catheter-related bloodstream infection by continuous infusion of low-dose unfractionated heparin in patients with hematologic and oncologic disease. J Clin Oncol 2005; 23(31): 7864-70.
9. Johnson DW, MacGinley R, Kay TD, Hawley CM, Campbell SB, Isbel NM, et al. A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters. Nephrol Dial Transplant 2002; 17(10): 1802-7.
10. Randolph AG, Cook DJ, Gonzales CA, Brun-Buisson C. Tunneling short-term central venous catheters to prevent catheter-related infection: a meta-analysis of randomized, controlled trials. Crit Care Med 1998; 26(8): 1452-7.
11. Timsit JF, Sebille V, Farkas JC, Misset B, Martin JB, Chevret S, et al. Effect of subcutaneous tunneling on internal jugular catheter-related sepsis in critically ill patients: a prospective randomized multicenter study. JAMA 1996; 276(17): 1416-20.
12. Hill RL, Fisher AP, Ware RJ, Wilson S, Casewell MW. Mupirocin for the reduction of colonization of internal jugular cannulae: a randomized controlled trial. J Hosp Infect 1990; 15(4): 311-21.
13. Sesso R, Barbosa D, Leme IL, Sader H, Canziani ME, Manfredi S, et al. Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter: effect of mupirocin ointment. J Am Soc Nephrol 1998; 9(6): 1085-92.
14. Hill RL, Casewell MW. Nasal carriage of MRSA: the role of mupirocin and outlook for resistance. Drugs Exp Clin Res 1990; 16(8): 397-402.
15. Cookson BD, Lacey RW, Noble WC, Reeves DS, Wise R, Redhead RJ. Mupirocin-resistant Staphylococcus aureus. Lancet 1990; 335(8697): 1095-6.
16. Snydman DR, Gorbea HF, Pober BR, Majka JA, Murray SA, Perry LK. Predictive value of surveillance skin cultures in total-parenteral-nutrition- related infection. Lancet 1982; 2(8312): 1385-8.
17. Zinner SH, Denny-Brown BC, Braun P, Burke JP, Toala P, Kass EH. Risk of infection with intravenous indwelling catheters: effect of application of antibiotic ointment. J Infect Dis 1969; 120(5): 616-9.
18. Levin A, Mason AJ, Jindal KK, Fong IW, Goldstein MB. Prevention of hemodialysis subclavian vein catheter infections by topical povidone-iodine. Kidney Int 1991; 40(5): 934-8.
19. Prager RL, Silva J Jr. Colonization of central venous catheters. South Med J 1984; 77(4): 458-61.
20. Maki DG, Band JD. A comparative study of polyantibiotic and iodophor ointments in prevention of vascular catheter-related infection. Am J Med 1981; 70(3): 739-44.
21. Papadopoulou C, Afkou Z, Kythreotou G, Tokatlidou D, Tsivitanidou M, Sofianou D. Positive central venous catheter cultures and bloodstream infections. Proceedings of the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID). Nice: France, 2006.
22. Bach A. Prevention of infections caused by central venous catheters - established and novel measures. Infection 1999; 27 Suppl 1: S11-5.
23. Banton J. Techniques to prevent central venous catheter infections: products, research, and recommendations. Nutr Clin Pract 2006; 21(1): 56-61.
24. Randolph AG. An evidence-based approach to central venous catheter management to prevent catheter-related infection in critically ill patients. Crit Care Clin 1998; 14(3): 411-21.
25. Conly JM, Grieves K, Peters B. A prospective, randomized study comparing transparent and dry gauze dressings for central venous catheters. J Infect Dis 1989; 159(2): 310-9.
26. Hill RL, Casewell MW. Reduction in the colonization of central venous cannulae by mupirocin. J Hos Infect 1991; 19 Suppl B: 47-57.
27. Riu S, Ruiz CG, Martinez-Vea A, Peralta C, Oliver JA. Spontaneous rupture of polyurethane peritoneal catheter. A possible deleterious effect of mupirocin ointment. Nephrol Dial Transplant 1998; 13(7): 1870-1.
28. National Nosocomial Infections Surveillance (NNIS) system report, data summary from January 1992-April 2000, issued June 2000. Am J Infect Control 2000; 28(6): 429-48.